
FG grants N24bn tax waivers to drug makers for 2025-2026
The federal government granted N24 billion in tax waivers to pharmaceutical manufacturers for 2025 and 2026. The waivers aim to increase local production of medicines and cut reliance on imported healthcare products. The incentives fall under a 2024 presidential executive order. Officials say the move is linked to 12 technology-transfer agreements and potential investments over $5 billion.
Background: The disclosure came from the Coordinating Minister of Health and Social Welfare, Muhammad Pate, during the 2026 Nigeria Health Sector Joint Annual Review in Abuja. The executive order was signed in 2024 to back domestic manufacturing of medicines, medical equipment and other essential healthcare products.
Pidgin: Federal government don give drug companies N24 billion tax waivers for 2025 and 2026. Dem wan use am boost local production of medicine and cut dependence on imported health products. The incentives come under presidential executive order wey dem sign for 2024. Officials talk say e connect to 12 technology-transfer agreements and potential investments wey pass $5 billion.
How this affects you: Pharmaceutical manufacturers will pay less tax on their operations in 2025 and 2026. This could lower the cost of locally made medicines for patients and residents who buy drugs. It may also create jobs for workers in the health manufacturing sector across Nigeria.
Share on WhatsAppJoin the debate
No comments yet. Be the first.
